Jenny Craig, Inc.
11
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
18.2%
2 terminated/withdrawn out of 11 trials
77.8%
-8.7% vs industry average
0%
0 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Insulin Variance Throughout the Day
Role: collaborator
Combined Effects of Sequential Variety and Portion Size on Meal Intake of Women
Role: collaborator
Combined Effects of Simultaneous Variety and Portion Size on Meal Intake of Women
Role: collaborator
Combined Effects of Variety and Portion Size on Meal Intake of Women
Role: collaborator
Effects of Variety and Portion Size on Meal Intake of Adults
Role: collaborator
Effect of 14:10 Time-Restricted Eating on Body Weight and Metabolic Markers
Role: lead
The Influence of Satiation Measures on the Portion Size Effect
Role: collaborator
Portion Size and To-go Container on Dinner Intake
Role: collaborator
Weight Loss and Abdominal Fat Responses to Different Diet Compositions
Role: collaborator
Food, Activity and Behavior Trial
Role: lead
Acute Glycemic Effects of a Very Low Fat Diet in Type 2 Diabetes
Role: collaborator
All 11 trials loaded